Where DHA powder is permitted, and what the file must show
DHA is sold as a food supplement ingredient in the EU, the US and the UK, but the route and the file depend on the oil source and the form. The catalog entry fixes the powder, not the source; the specification must name whether the oil is algal or fish, because the allergen, the novel-food route and the label follow from that. The file also has to show contaminants, the claim boundary and the documents behind the lot.
Permission is not a property of the powder alone: the source, the market and the label each have to be shown in the file.
Four checks, not one
A DHA ingredient is checked at four levels: the ingredient route, the food category, the contaminants and the label with its claim. They fail independently. A lot can meet the heavy-metal limits and sit on the wrong source route; a route can be correct and the label omit a fish allergen. A supplier statement answers one of the four.
The powder specification is the starting point, not the answer. The market file adds the source, the use level, the label and the claim to the catalog limits.
The European Union
Food supplements are governed by Directive 2002/46/EC, which harmonises the vitamin and mineral lists but leaves other substances, including fatty acids, to national rules and the general food law. On top sits the novel-food Regulation (EU) 2015/2283: a food not consumed significantly in the EU before 15 May 1997 needs an authorisation, and authorised novel foods appear in the Union list in Regulation (EU) 2017/2470 with their conditions of use.
If the oil is algal, the DHA-rich oil from microalgae is the route to check: the Union list entry carries the conditions of use and label designation, and the supplier should point to the entry relied on. If the oil is fish, the novel-food question differs, but the source brings the allergen and contaminant file. Ask for the source statement before any “EU compliant” letter.
Labelling follows Regulation (EU) 1169/2011: ingredient list, allergen emphasis, nutrition declaration and the quantitative ingredient declaration where a component is emphasised. Contaminants are governed by Regulation (EU) 2023/915 at this review; check the current text, because the levels and supplement entries are revised.
The United States
In the US, a DHA powder for supplements is a dietary ingredient under DSHEA. The FDA does not approve supplements or labels before marketing, so there is no pre-market licence. The framework is safety and labelling: the ingredient must be lawful, the facility follows the dietary-supplement GMPs in 21 CFR 111, and the label follows 21 CFR 101.
A new dietary ingredient needs a notification at least 75 days before marketing unless its history of use removes that requirement. GRAS is a separate route, and a GRAS conclusion belongs to a specific substance, source and use, not to “DHA” in general. Keep the route reference.
Fish is a major food allergen under FALCPA; an algal oil is not fish, but the carrier and antioxidant can introduce an allergen. Modified starch may come from corn, potato, tapioca or wheat, and wheat is a major allergen. The source statement should cover the oil, the starch and the antioxidant, not only DHA.
The United Kingdom
The UK applies a retained framework: supplements, labelling, contaminants and claims follow retained EU law as amended, enforced by the Food Standards Agency. Novel foods are on the GB register, and a supplier should identify the entry relied on. Northern Ireland applies the EU regime.
The allergen list is the retained Annex II list, so fish and wheat matter as in the EU. The claims register is the GB register; wording authorised in the EU is not automatically authorised in GB. Check the register for the destination, not the source market.
Contaminants and the specification
| Parameter | Catalog limit | File note |
|---|---|---|
| Lead | ≤3 mg/kg | Compare with the current EU or UK maximum and the customer's limit |
| Arsenic | ≤2 mg/kg | Speciation and the applicable limit depend on the market |
| Cadmium | ≤1 mg/kg | Check the current supplement entry |
| Mercury | ≤0.1 mg/kg | Relevant to a fish-oil source in particular |
| Peroxide value | ≤5.0 meq/kg | A lipid-quality limit, not a contaminant maximum |
| p-Anisidine value | ≤20.0 | Read with the peroxide value, not instead of it |
| Microbiology | APC ≤1,000 cfu/g; yeast and mould ≤100 cfu/g; E. coli and Salmonella absent | Confirm the customer's criteria and the method |
The catalog limits are release limits for the powder. The legal limit applies to the finished product, so run the calculation on the formula as well. A powder near the lead limit can fail in a product that adds another lead source. The COA page lists the tests.
The claim boundary
In the EU and the UK, health claims are governed by Regulation 1924/2006 and the applicable register. Only authorised claims may be used, with the wording, food category and intake condition of the entry. The register contains authorised claims for DHA; this page does not reproduce them, and a paraphrase is not a substitute.
In the US, a structure/function claim is allowed with the required disclaimer. A disease claim is not allowed unless it is an authorised qualified health claim; otherwise it turns the product into a drug. The wording decides, and enforcement is on the finished label. The brand owns the claim.
The boundary is the same in all three markets: describe what the material is and how it is tested; do not describe a disease, a disease-related use or a prevention. No disease-related claim belongs on a DHA specification, COA or label.
The file a buyer should hold
| Document | What it proves | Common gap |
|---|---|---|
| Specification | Grade, source, limits and methods | No source, carrier or allergen line |
| Batch COA | The lot was released against the specification | Results copied from the range |
| Source and allergen statement | Algal or fish oil; starch and antioxidant sources | “Fish-free” claimed without a source statement |
| Novel-food or route reference (EU/UK) | Which entry the material relies on | Generic “EU compliant” letter |
| NDI or GRAS reference (US) | The safety route for the source and use | GRAS cited for a different source |
| Contaminant and micro data | The lot meets the agreed limits | Panel without methods or LOQs |
| Stability data and SDS | Storage, handling and shelf life | Shelf life with no study behind it |
The compliance checklist
- Name the oil source and grade, and match them to the destination route.
- Confirm the DHA content, the assay basis and the method on the specification.
- Check the allergen statement against oil, starch and antioxidant.
- Compare lead, arsenic, cadmium, mercury and microbiology with the limits.
- Check the label designation, ingredient list, nutrition declaration and storage.
- Keep the claim inside the register; no disease-related wording.
- Hold COA, specification, SDS and stability data in one dated file.
- Re-check the route when the source, grade or market changes.
The route references are on the EU, US and UK regulatory pages. The allergen list is in the Annex II entry, the source decision is on the grade page, and the hub carries the catalog specification.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation